OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Mohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1134-1151.e10
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Tertiary lymphoid structures in anticancer immunity
Jean‐Luc Teillaud, Ana Houel, Marylou Panouillot, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 9, pp. 629-646
Closed Access | Times Cited: 30

Glioblastoma vaccines: past, present, and opportunities
Zujian Xiong, Itay Raphael, Michael R. Olin, et al.
EBioMedicine (2024) Vol. 100, pp. 104963-104963
Open Access | Times Cited: 29

Targeting the tumour vasculature: from vessel destruction to promotion
Sophie Guelfi, Kairbaan Hodivala‐Dilke, Gabriele Bergers
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 655-675
Closed Access | Times Cited: 26

In vivo dendritic cell reprogramming for cancer immunotherapy
Ervin Ascic, Fritiof Åkerström, M. Nair, et al.
Science (2024) Vol. 386, Iss. 6719
Open Access | Times Cited: 20

Tertiary lymphoid structures in cancer: maturation and induction
Yulu Chen, Yuhao Wu, Guorong Yan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18

Brain-Targeting Drug Delivery Systems: The State Of The Art In Treatment Of Glioblastoma
Bo Sun, Rong Li, Ning Ji, et al.
Materials Today Bio (2025) Vol. 30, pp. 101443-101443
Open Access | Times Cited: 3

Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside
Florent Peyraud, Jean‐Philippe Guégan, Lucile Vanhersecke, et al.
Med (2025) Vol. 6, Iss. 1, pp. 100546-100546
Closed Access | Times Cited: 2

Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances
Lianyu Zhao, Song Jin, Shengyao Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 15

Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy
Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Cancer Research (2024) Vol. 84, Iss. 8, pp. 1199-1209
Open Access | Times Cited: 12

Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
Michael Croft, Shahram Salek‐Ardakani, Carl F. Ware
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 939-961
Closed Access | Times Cited: 10

T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle
Wen‐Ping Lin, Hao Li, Zhi‐Jun Sun
EBioMedicine (2024) Vol. 104, pp. 105154-105154
Open Access | Times Cited: 9

The prognostic significance of tertiary lymphoid structures in oral squamous cell carcinomas: a systematic review
Vitória Araújo Gonçalves Ribeiro, Jean‐Luc Teillaud, Marie‐Caroline Dieu‐Nosjean, et al.
Frontiers in Oral Health (2025) Vol. 5
Open Access | Times Cited: 1

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade
Christina A. Von Roemeling, Jeet A. Patel, Savannah Carpenter, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5

Cerebral biomimetic nano-drug delivery systems: A frontier strategy for immunotherapy
Hao Tian, Jiaxin Yao, Qi Ba, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 1039-1067
Closed Access | Times Cited: 4

Protocol for in vivo immune cell analysis in subcutaneous murine tumor models using advanced flow cytometry
Katrine Ingelshed, Marit M. Melssen, Diana Spiegelberg
STAR Protocols (2025) Vol. 6, Iss. 1, pp. 103505-103505
Closed Access

Tertiary Lymphoid Structures as a Biomarker in Immunotherapy and Beyond: Advancing Towards Clinical Application
Xinyu Cui, Xuanyu Gu, Dongyu Li, et al.
Cancer Letters (2025), pp. 217491-217491
Closed Access

From heterogeneity to prognosis: understanding the complexity of tertiary lymphoid structures in tumors
Yingying Wang, Dongyan Zhang, Xueping Huang, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

B cells in non-lymphoid tissues
Abrar Samiea, George Celis, Rashi Yadav, et al.
Nature reviews. Immunology (2025)
Closed Access

Intratumoral gene delivery of 4-1BBL boosts IL-12-triggered anti-glioblastoma immunity
Taral R. Lunavat, Lisa Nieland, Sanne M. van de Looij, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

An Early Progression Biomarker in Glioblastoma: Microcirculatory Heterogeneity on Ultrasound Localization Microscopy
Xing Hu, Gaobo Zhang, Xiandi Zhang, et al.
Ultrasound in Medicine & Biology (2025)
Closed Access

Prognostic implications and characterization of tumor-associated tertiary lymphoid structures genes in pancreatic cancer
Enkui Zhang, Yongsu Ma, Zonghao Liu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

HSV-1 as a gene delivery platform for cancer gene therapy
Yangkun Shen, Hucheng Zhang, Mengzhou Xue, et al.
Trends in Pharmacological Sciences (2025)
Closed Access

Page 1 - Next Page

Scroll to top